What is he best known for?
The fields of study he is best known for:
- Cancer
- Internal medicine
- Gene
Pathology, Cancer research, Prostate cancer, Internal medicine and Prostate are his primary areas of study.
Pathology is closely attributed to Adenocarcinoma in his study.
His Prostate cancer research is under the purview of Cancer.
His research in Internal medicine intersects with topics in Gastroenterology, Endocrinology and Oncology.
The Prostatectomy research Lukas Bubendorf does as part of his general Prostate study is frequently linked to other disciplines of science, such as XIAP, therefore creating a link between diverse domains of science.
His Tissue microarray study integrates concerns from other disciplines, such as In situ hybridization, Complementary DNA, Microarray, DNA microarray and Fluorescence in situ hybridization.
His most cited work include:
- Tissue microarrays for high-throughput molecular profiling of tumor specimens (3700 citations)
- Gene-Expression Profiles in Hereditary Breast Cancer (1533 citations)
- Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients. (1213 citations)
What are the main themes of his work throughout his whole career to date?
Lukas Bubendorf mainly focuses on Pathology, Internal medicine, Oncology, Prostate cancer and Cancer research.
His research integrates issues of Fluorescence in situ hybridization and Adenocarcinoma in his study of Pathology.
His Internal medicine research includes elements of Gastroenterology and Endocrinology.
The study incorporates disciplines such as Stage, Disease, Chemotherapy and Predictive marker in addition to Oncology.
His Prostate cancer study combines topics from a wide range of disciplines, such as Prostate and Tissue microarray.
His Cancer research study incorporates themes from Carcinogenesis, Tumor suppressor gene, Cancer cell, Metastasis and Tumor progression.
He most often published in these fields:
- Pathology (35.02%)
- Internal medicine (34.78%)
- Oncology (26.33%)
What were the highlights of his more recent work (between 2018-2021)?
- Internal medicine (34.78%)
- Lung cancer (20.29%)
- Oncology (26.33%)
In recent papers he was focusing on the following fields of study:
His primary areas of study are Internal medicine, Lung cancer, Oncology, Pathology and Cancer research.
In the field of Internal medicine, his study on Immunohistochemistry, Biomarker, Clinical trial and Pembrolizumab overlaps with subjects such as In patient.
His research on Immunohistochemistry focuses in particular on Tissue microarray.
His biological study spans a wide range of topics, including Liquid biopsy, PD-L1, Prostate cancer and Predictive biomarker.
The Pathology study combines topics in areas such as Molecular pathology and Lung.
His work deals with themes such as Cancer, Adenocarcinoma, Gene, Somatic evolution in cancer and PTEN, which intersect with Cancer research.
Between 2018 and 2021, his most popular works were:
- Best Practices Recommendations for Diagnostic Immunohistochemistry in Lung Cancer (80 citations)
- PD-L1 Testing for Lung Cancer in 2019 : Perspective From the IASLC Pathology Committee (57 citations)
- Trastuzumab Emtansine (T-DM1) in Patients with Previously Treated HER2-Overexpressing Metastatic Non–Small Cell Lung Cancer: Efficacy, Safety, and Biomarkers (51 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Gene
His primary scientific interests are in Internal medicine, Lung cancer, Oncology, Immunohistochemistry and Pathology.
His Malignancy and Who classification study in the realm of Internal medicine interacts with subjects such as NUT midline carcinoma and Appropriate use.
Lukas Bubendorf combines subjects such as Mutation, Predictive biomarker, Clinical trial and Immunotherapy with his study of Lung cancer.
In general Immunohistochemistry, his work in Tissue microarray is often linked to Best practice linking many areas of study.
His work on Pathology is being expanded to include thematically relevant topics such as Androgen receptor.
His work in Liquid biopsy addresses subjects such as Progressive disease, which are connected to disciplines such as Prostate cancer.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
